1. 首都医科大学附属北京中医医院耳鼻咽喉科
扫 描 看 全 文
[1]闫新宇,韩金帅,黄少霆,赵竞一,盖建青,王俊阁.息敏煎治疗肺肾虚寒型变应性鼻炎的临床疗效[J].北京中医药,2020,39(06):543-547.
YAN Xin-yu, HAN Jin-shuai, HUANG Shao-ting, et al. Clinical effect of Ximin Decoction on allergic rhinitis of deficient cold of lung and kidney type[J]. Beijing Journal of Traditional Chinese Medicine, 2020,39(6):543-547.
[1]闫新宇,韩金帅,黄少霆,赵竞一,盖建青,王俊阁.息敏煎治疗肺肾虚寒型变应性鼻炎的临床疗效[J].北京中医药,2020,39(06):543-547. DOI: 10.16025/j.1674-1307.2020.06.006.
YAN Xin-yu, HAN Jin-shuai, HUANG Shao-ting, et al. Clinical effect of Ximin Decoction on allergic rhinitis of deficient cold of lung and kidney type[J]. Beijing Journal of Traditional Chinese Medicine, 2020,39(6):543-547. DOI: 10.16025/j.1674-1307.2020.06.006.
目的观察息敏煎治疗肺肾虚寒型变应性鼻炎的临床疗效。方法选取2017年5月—2018年10月首都医科大学附属北京中医医院耳鼻咽喉科确诊的100例肺肾虚寒型变应性鼻炎(常年性)患者随机分为治疗组和对照组,各50例。治疗组予息敏煎治疗,对照组予丙酸氟替卡松喷鼻和氯雷他定口服治疗,2组均治疗4周。评价2组治疗前后临床症状评分和生活质量评分,检测治疗前后外周血INF-γ、IL-2、IL-4、IL-5、TGF-β、IL-17水平。结果治疗组总有效率为96.0%,对照组为98.0%,2组差异无统计学意义(P>0.05);临床控制+显著改善率治疗组为84.0%,对照组为80.0%,差异无统计(P>0.05)。组治疗后鼻炎症状评分(TNSS)总评分比较差异无统计学意义(t=1.232,P>0.05)。治疗组治疗前后简化版鼻结膜炎相关生活质量问卷(RQLQ)总评分比较差异有统计学意义(t=52.43,P<0.01),对照组治疗前后RQLQ总评分比较差异有统计学意义(t=37.41,P<0.01);治疗组和对照组治疗后RQLQ总评分比较差异有统计学意义(t=3.006,P<0.01)。治疗组和对照组治疗后吸气时左、右及总鼻阻力,呼气时左、右及总鼻阻力6组数据比较,差异均无统计学意义(P>0.05)。治疗组和对照组治疗后左、右鼻腔容积及左、右鼻腔最小横截面积4组数据比较,差异均无统计学意义(P>0.05)。治疗组INF-γ、IL-2、TGF-β水平治疗后明显增高(P<0.01),IL-4、IL-5、IL-17水平明显降低(P<0.01),对照组INF-γ、IL-2、IL-4、IL-5、TGF-β、IL-17水平治疗前后差异有统计学意义(P<0.01)。结论息敏煎治疗肺肾虚寒型变应性鼻炎患者具有很好地改善鼻部和全身症状的作用,息敏煎能够改善体内免疫平衡状态。
Objective To observe the clinical effect of Ximin Decoction on allergic rhinitis of deficient cold of lung and kidney type.Methods 100 confirmed cases of perennial allergic rhinitis in the Otolaryngology Department of the Beijing Hospital of Traditional Chinese Medicine from May 2017 to October 2018 were randomly divided into treatment group and control group, 50 cases in each.The treatment group was given Ximin decoction, while the control group was given flixonase nasal spray and/or loratadine tablets, all patients were treated for 4 weeks.Scores of clinical symptoms and RQLQ were evaluated before and after treatment, and INF-γ, IL-2, IL-4, IL-5, TGF-β, IL-17 levels in peripheral blood were detected.Results The total effective rate was 96% in the treatment group and 98.0% in the control group, no statistically significant difference was found(P>0.05); the clinical control + significant improvement rate was 84.0% in the treatment group and 80.0% in the control group without the difference statistically significant(P >0.05); the TNSS total scores of both groups after treatment showed no statistical significance(t=1.323, P>0.05); the RQLQ total score of the treatment group before and after treatment was statistically significant(t=52.43, P<0.01), the RQLQ total score of the control group before and after treatment was statistically significant(t=37.41, P<0.01); the difference of total scores of RQLQ in the treatment group and the control group was statistically significant(t=3.006, P<0.01); no statistical difference was found between the six groups in left, right and total nasal resistance in inhalation and exhalation(P > 0.05).No statistical difference was found between the four groups in left and right nasal cavity volume and the minimum cross section area(P > 0.05).The levels of INF-γ, IL-2 and TGF-β in the treatment group were significantly increased(P<0.01)after treatment, and the levels of IL-4, IL-5 and IL-17 were significantly decreased(P<0.01), the levels of those factors were statistically significant in the control group before and after the treatment(P<0.01).Conclusion Ximin Decoction could help relieve nasal and systemic symptoms of allergic rhinitis of deficient cold of lung and kidney type and improve the immune equilibrium.
变应性鼻炎息敏煎细胞因子
Allergic rhinitisXimin Decoctioncytokine
0
浏览量
82
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构